Distinct clinic-pathological features of early differentiated-type gastric cancers after helicobacter pylori eradication

Noriyuki Horiguchi, Tomomitsu Tahara, Tomohiko Kawamura, Masaaki Okubo, Takamitsu Ishizuka, Yoshihito Nakagawa, Mitsuo Nagasaka, Tomoyuki Shibata, Naoki Omiya

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background. Gastric cancer is discovered even after successful eradication of H. pylori. We investigated clinic pathological features of early gastric cancers after H. pylori eradication. Methods. 51 early gastric cancers (EGCs) from 44 patients diagnosed after successful H. pylori eradication were included as eradication group. The clinic-pathological features were compared with that of 131 EGCs from 120 patients who did not have a history of H. pylori eradication (control group). Results. Compared with control group, clinic-pathological features of eradication group were characterized as depressed (p < 0.0001), reddish (p = 0.0001), and smaller (p = 0.0095) lesions, which was also confirmed in the comparison of six metachronous lesions diagnosed after initial ESD and subsequent successful H. pylori eradication. Prevalence of both SM2 (submucosal invasion greater than 500 μm) and unexpected SM2 cases tended to be higher in eradication group (p = 0.077, 0.0867, resp.). Prevalence of inconclusive diagnosis of gastric cancer during pretreatment biopsy was also higher in the same group (26.0% versus 1.6%, p < 0.0001). Conclusions. Informative clinic pathological features of EGC after H. pylori eradication are depressed, reddish appearances, which should be treated as a caution because histological diagnosis of cancerous tissue is sometimes difficult by endoscopic biopsy.

Original languageEnglish
Article number8230815
JournalGastroenterology Research and Practice
Volume2016
DOIs
Publication statusPublished - 01-01-2016

Fingerprint

Helicobacter pylori
Stomach Neoplasms
Biopsy
Control Groups

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Horiguchi, Noriyuki ; Tahara, Tomomitsu ; Kawamura, Tomohiko ; Okubo, Masaaki ; Ishizuka, Takamitsu ; Nakagawa, Yoshihito ; Nagasaka, Mitsuo ; Shibata, Tomoyuki ; Omiya, Naoki. / Distinct clinic-pathological features of early differentiated-type gastric cancers after helicobacter pylori eradication. In: Gastroenterology Research and Practice. 2016 ; Vol. 2016.
@article{6b0b0646f0f948a08b2602cf44143a1b,
title = "Distinct clinic-pathological features of early differentiated-type gastric cancers after helicobacter pylori eradication",
abstract = "Background. Gastric cancer is discovered even after successful eradication of H. pylori. We investigated clinic pathological features of early gastric cancers after H. pylori eradication. Methods. 51 early gastric cancers (EGCs) from 44 patients diagnosed after successful H. pylori eradication were included as eradication group. The clinic-pathological features were compared with that of 131 EGCs from 120 patients who did not have a history of H. pylori eradication (control group). Results. Compared with control group, clinic-pathological features of eradication group were characterized as depressed (p < 0.0001), reddish (p = 0.0001), and smaller (p = 0.0095) lesions, which was also confirmed in the comparison of six metachronous lesions diagnosed after initial ESD and subsequent successful H. pylori eradication. Prevalence of both SM2 (submucosal invasion greater than 500 μm) and unexpected SM2 cases tended to be higher in eradication group (p = 0.077, 0.0867, resp.). Prevalence of inconclusive diagnosis of gastric cancer during pretreatment biopsy was also higher in the same group (26.0{\%} versus 1.6{\%}, p < 0.0001). Conclusions. Informative clinic pathological features of EGC after H. pylori eradication are depressed, reddish appearances, which should be treated as a caution because histological diagnosis of cancerous tissue is sometimes difficult by endoscopic biopsy.",
author = "Noriyuki Horiguchi and Tomomitsu Tahara and Tomohiko Kawamura and Masaaki Okubo and Takamitsu Ishizuka and Yoshihito Nakagawa and Mitsuo Nagasaka and Tomoyuki Shibata and Naoki Omiya",
year = "2016",
month = "1",
day = "1",
doi = "10.1155/2016/8230815",
language = "English",
volume = "2016",
journal = "Gastroenterology Research and Practice",
issn = "1687-6121",
publisher = "Hindawi Publishing Corporation",

}

Distinct clinic-pathological features of early differentiated-type gastric cancers after helicobacter pylori eradication. / Horiguchi, Noriyuki; Tahara, Tomomitsu; Kawamura, Tomohiko; Okubo, Masaaki; Ishizuka, Takamitsu; Nakagawa, Yoshihito; Nagasaka, Mitsuo; Shibata, Tomoyuki; Omiya, Naoki.

In: Gastroenterology Research and Practice, Vol. 2016, 8230815, 01.01.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Distinct clinic-pathological features of early differentiated-type gastric cancers after helicobacter pylori eradication

AU - Horiguchi, Noriyuki

AU - Tahara, Tomomitsu

AU - Kawamura, Tomohiko

AU - Okubo, Masaaki

AU - Ishizuka, Takamitsu

AU - Nakagawa, Yoshihito

AU - Nagasaka, Mitsuo

AU - Shibata, Tomoyuki

AU - Omiya, Naoki

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background. Gastric cancer is discovered even after successful eradication of H. pylori. We investigated clinic pathological features of early gastric cancers after H. pylori eradication. Methods. 51 early gastric cancers (EGCs) from 44 patients diagnosed after successful H. pylori eradication were included as eradication group. The clinic-pathological features were compared with that of 131 EGCs from 120 patients who did not have a history of H. pylori eradication (control group). Results. Compared with control group, clinic-pathological features of eradication group were characterized as depressed (p < 0.0001), reddish (p = 0.0001), and smaller (p = 0.0095) lesions, which was also confirmed in the comparison of six metachronous lesions diagnosed after initial ESD and subsequent successful H. pylori eradication. Prevalence of both SM2 (submucosal invasion greater than 500 μm) and unexpected SM2 cases tended to be higher in eradication group (p = 0.077, 0.0867, resp.). Prevalence of inconclusive diagnosis of gastric cancer during pretreatment biopsy was also higher in the same group (26.0% versus 1.6%, p < 0.0001). Conclusions. Informative clinic pathological features of EGC after H. pylori eradication are depressed, reddish appearances, which should be treated as a caution because histological diagnosis of cancerous tissue is sometimes difficult by endoscopic biopsy.

AB - Background. Gastric cancer is discovered even after successful eradication of H. pylori. We investigated clinic pathological features of early gastric cancers after H. pylori eradication. Methods. 51 early gastric cancers (EGCs) from 44 patients diagnosed after successful H. pylori eradication were included as eradication group. The clinic-pathological features were compared with that of 131 EGCs from 120 patients who did not have a history of H. pylori eradication (control group). Results. Compared with control group, clinic-pathological features of eradication group were characterized as depressed (p < 0.0001), reddish (p = 0.0001), and smaller (p = 0.0095) lesions, which was also confirmed in the comparison of six metachronous lesions diagnosed after initial ESD and subsequent successful H. pylori eradication. Prevalence of both SM2 (submucosal invasion greater than 500 μm) and unexpected SM2 cases tended to be higher in eradication group (p = 0.077, 0.0867, resp.). Prevalence of inconclusive diagnosis of gastric cancer during pretreatment biopsy was also higher in the same group (26.0% versus 1.6%, p < 0.0001). Conclusions. Informative clinic pathological features of EGC after H. pylori eradication are depressed, reddish appearances, which should be treated as a caution because histological diagnosis of cancerous tissue is sometimes difficult by endoscopic biopsy.

UR - http://www.scopus.com/inward/record.url?scp=84973438931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973438931&partnerID=8YFLogxK

U2 - 10.1155/2016/8230815

DO - 10.1155/2016/8230815

M3 - Article

AN - SCOPUS:84973438931

VL - 2016

JO - Gastroenterology Research and Practice

JF - Gastroenterology Research and Practice

SN - 1687-6121

M1 - 8230815

ER -